BETH BROWN: Open Payments
NPI 1184958837 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 84 payments from 10 companies in 2025. Trend: 2023 $1,679 · 2024 $1,831 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $357 |
| Collegium Pharmaceutical, Inc. | 17 | $333 |
| VERTEX PHARMACEUTICALS INCORPORATED | 9 | $307 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $281 |
| PFIZER INC. | 14 | $245 |
| Azurity Pharmaceuticals, Inc. | 6 | $138 |
| SCILEX PHARMACEUTICALS INC. | 3 | $62 |
| IBSA Pharma Inc. | 1 | $27 |
| Tonix Medicines, Inc. | 1 | $16 |
| MML US, Inc. | 1 | $6 |
Products named: Belbuca, RELISTOR, JOURNAVX, NURTEC ODT, UBRELVY, QULIPTA, HORIZANT, ZTLido.
Industry payments across CA — which companies pay providers there.
